• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌进展过程中基因改变的发生情况。

The Occurrence of Genetic Alterations during the Progression of Breast Carcinoma.

作者信息

Li Xiao-Chen, Liu Chenglin, Huang Tao, Zhong Yang

机构信息

School of Life Sciences, Fudan University, Shanghai 200433, China.

School of Life Sciences and Biotechnology, Shanghai Jiaotong University, Shanghai 200240, China.

出版信息

Biomed Res Int. 2016;2016:5237827. doi: 10.1155/2016/5237827. Epub 2016 Apr 14.

DOI:10.1155/2016/5237827
PMID:27190992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4848409/
Abstract

The interrelationship among genetic variations between the developing process of carcinoma and the order of occurrence has not been completely understood. Interpreting the mechanisms of copy number variation (CNV) is absolutely necessary for understanding the etiology of genetic disorders. Oncogenetic tree is a special phylogenetic tree inferential pictorial representation of oncogenesis. In our present study, we constructed oncogenetic tree to imitate the occurrence of genetic and cytogenetic alterations in human breast cancer. The oncogenetic tree model was built on CNV of ErbB2, AKT2, KRAS, PIK3CA, PTEN, and CCND1 genes in 963 cases of tumors with sequencing and CNA data of human breast cancer from TCGA. Results from the oncogenetic tree model indicate that ErbB2 copy number variation is the frequent early event of human breast cancer. The oncogenetic tree model based on the phylogenetic tree is a type of mathematical model that may eventually provide a better way to understand the process of oncogenesis.

摘要

癌症发生发展过程中基因变异之间的相互关系以及发生顺序尚未完全明晰。解读拷贝数变异(CNV)的机制对于理解遗传疾病的病因绝对必要。肿瘤发生树是肿瘤发生过程的一种特殊系统发育树推断性图形表示。在我们目前的研究中,我们构建肿瘤发生树以模拟人类乳腺癌中遗传和细胞遗传学改变的发生情况。该肿瘤发生树模型基于来自TCGA的963例具有测序和CNA数据的人类乳腺癌肿瘤中ErbB2、AKT2、KRAS、PIK3CA、PTEN和CCND1基因的CNV构建。肿瘤发生树模型的结果表明,ErbB2拷贝数变异是人类乳腺癌常见的早期事件。基于系统发育树的肿瘤发生树模型是一种数学模型,最终可能会为理解肿瘤发生过程提供更好的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c04/4848409/e5221bfa4847/BMRI2016-5237827.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c04/4848409/ccafb8fc560d/BMRI2016-5237827.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c04/4848409/c42c42cc2a79/BMRI2016-5237827.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c04/4848409/e5221bfa4847/BMRI2016-5237827.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c04/4848409/ccafb8fc560d/BMRI2016-5237827.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c04/4848409/c42c42cc2a79/BMRI2016-5237827.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c04/4848409/e5221bfa4847/BMRI2016-5237827.003.jpg

相似文献

1
The Occurrence of Genetic Alterations during the Progression of Breast Carcinoma.乳腺癌进展过程中基因改变的发生情况。
Biomed Res Int. 2016;2016:5237827. doi: 10.1155/2016/5237827. Epub 2016 Apr 14.
2
Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.非小细胞肺癌中表皮生长因子受体信号通路基因的体细胞突变。
J Thorac Oncol. 2010 Nov;5(11):1734-40. doi: 10.1097/JTO.0b013e3181f0beca.
3
CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast.乳腺浸润性小叶癌中CCND1和ERBB2基因失调及PTEN突变分析
Mol Carcinog. 2002 Sep;35(1):6-12. doi: 10.1002/mc.10069.
4
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.评估 PIK3CA 突变和 PTEN 缺失与曲妥珠单抗治疗转移性乳腺癌疗效的关系。
Breast Cancer Res Treat. 2011 Jul;128(2):447-56. doi: 10.1007/s10549-011-1572-5. Epub 2011 May 19.
5
Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women.中国女性乳腺癌PI3K/AKT/mTOR通路激活与预后的相关性
PLoS One. 2015 Mar 27;10(3):e0120511. doi: 10.1371/journal.pone.0120511. eCollection 2015.
6
Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.间变性甲状腺癌和滤泡状甲状腺癌中受体酪氨酸激酶、磷脂酰肌醇3激酶/蛋白激酶B及丝裂原活化蛋白激酶信号通路中高度普遍的基因改变
J Clin Endocrinol Metab. 2008 Aug;93(8):3106-16. doi: 10.1210/jc.2008-0273. Epub 2008 May 20.
7
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.在人类乳腺癌中,PIK3CA突变与激素受体、淋巴结转移及ERBB2相关,且与PTEN缺失相互排斥。
Cancer Res. 2005 Apr 1;65(7):2554-9. doi: 10.1158/0008-5472-CAN-04-3913.
8
PI3K/AKT pathway activation in bladder carcinogenesis.在膀胱癌发生过程中 PI3K/AKT 通路的激活。
Int J Cancer. 2014 Apr 15;134(8):1776-84. doi: 10.1002/ijc.28518. Epub 2013 Oct 24.
9
Correlation of breast cancer axillary lymph node metastases with stem cell mutations.乳腺癌腋窝淋巴结转移与干细胞突变的相关性。
JAMA Surg. 2013 Sep;148(9):873-8. doi: 10.1001/jamasurg.2013.3028.
10
ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.表皮生长因子受体2/神经生长因子受体激酶通过多种信号通路调节细胞周期蛋白依赖性激酶抑制因子2和细胞周期蛋白D1。
Cancer Res. 2001 Sep 1;61(17):6583-91.

引用本文的文献

1
Copy number variation heterogeneity reveals biological inconsistency in hierarchical cancer classifications.拷贝数变异异质性揭示了癌症分级分类中的生物学不一致性。
Mol Cytogenet. 2024 Nov 6;17(1):26. doi: 10.1186/s13039-024-00692-2.
2
Multiclass Cancer Prediction Based on Copy Number Variation Using Deep Learning.基于深度学习的拷贝数变异的多癌症预测。
Comput Intell Neurosci. 2022 Jun 9;2022:4742986. doi: 10.1155/2022/4742986. eCollection 2022.
3
Smoking alters the evolutionary trajectory of non-small cell lung cancer.吸烟改变了非小细胞肺癌的进化轨迹。

本文引用的文献

1
Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets.信号转导网络分析突变和拷贝数变异可预测乳腺癌亚型特异性药物靶点。
Cell Rep. 2013 Oct 17;5(1):216-23. doi: 10.1016/j.celrep.2013.08.028. Epub 2013 Sep 26.
2
TrAp: a tree approach for fingerprinting subclonal tumor composition.TrAp:一种用于分析亚克隆肿瘤成分的树方法。
Nucleic Acids Res. 2013 Sep;41(17):e165. doi: 10.1093/nar/gkt641. Epub 2013 Jul 27.
3
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Exp Ther Med. 2019 Nov;18(5):3315-3324. doi: 10.3892/etm.2019.7958. Epub 2019 Aug 29.
4
Identifying Methylation Pattern and Genes Associated with Breast Cancer Subtypes.鉴定与乳腺癌亚型相关的甲基化模式和基因。
Int J Mol Sci. 2019 Aug 31;20(17):4269. doi: 10.3390/ijms20174269.
2000 个乳腺肿瘤的基因组和转录组结构揭示了新的亚群。
Nature. 2012 Apr 18;486(7403):346-52. doi: 10.1038/nature10983.
4
Oncogenetic tree modeling of human hepatocarcinogenesis.人类肝癌发生的癌基因树建模。
Int J Cancer. 2012 Feb 1;130(3):575-83. doi: 10.1002/ijc.26063. Epub 2011 May 9.
5
Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines.人乳腺癌细胞系中的磷脂酰肌醇-3-羟基激酶或RAS途径突变。
Mol Cancer Res. 2007 Feb;5(2):195-201. doi: 10.1158/1541-7786.MCR-06-0263.
6
Maximum likelihood estimation of oncogenetic tree models.肿瘤发生树模型的最大似然估计。
Biostatistics. 2004 Oct;5(4):545-56. doi: 10.1093/biostatistics/kxh007.
7
Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.ErbB2受体的过表达抑制乳腺癌细胞中IGF-I诱导的Shc-MAPK信号通路。
Biochem Biophys Res Commun. 2004 Jan 16;313(3):709-15. doi: 10.1016/j.bbrc.2003.12.007.
8
Estimating an oncogenetic tree when false negatives and positives are present.在存在假阴性和假阳性的情况下估计肿瘤发生树。
Math Biosci. 2002 Apr;176(2):219-36. doi: 10.1016/s0025-5564(02)00086-x.
9
Distance-based reconstruction of tree models for oncogenesis.基于距离的肿瘤发生树模型重建。
J Comput Biol. 2000;7(6):789-803. doi: 10.1089/10665270050514936.
10
c-erbB2 oncoprotein expression, gene amplification, and chromosome 17 aneusomy in apocrine adenosis of the breast.乳腺大汗腺腺病中的c-erbB2癌蛋白表达、基因扩增及17号染色体非整倍体
J Pathol. 2000 Jun;191(2):138-42. doi: 10.1002/(SICI)1096-9896(200006)191:2<138::AID-PATH611>3.0.CO;2-J.